Processing

Please wait...

Settings

Settings

Goto Application

1. WO1998016543 - REMEDY FOR CHRONIC FATIGUE SYNDROME

Publication Number WO/1998/016543
Publication Date 23.04.1998
International Application No. PCT/JP1997/003658
International Filing Date 09.10.1997
Chapter 2 Demand Filed 17.04.1998
IPC
A61K 31/56 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
CPC
A61K 31/56
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
A61K 31/5685
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
565not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
568substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
5685having an oxo group in position 17, e.g. androsterone
Applicants
  • KANEBO, LIMITED [JP]/[JP] (AllExceptUS)
  • KURATSUNE, Hirohiko [JP]/[JP] (UsOnly)
  • KITANI, Teruo [JP]/[JP] (UsOnly)
  • SAWADA, Masumi [JP]/[JP] (UsOnly)
Inventors
  • KURATSUNE, Hirohiko
  • KITANI, Teruo
  • SAWADA, Masumi
Priority Data
8/29341314.10.1996JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) REMEDY FOR CHRONIC FATIGUE SYNDROME
(FR) MEDICAMENT CONTRE LE SYNDROME DE FATIGUE CHRONIQUE
Abstract
(EN)
A remedy for chronic fatigue syndrome (CFS) containing dehydroepiandrosterone sulfate (DHAS) or a pharmaceutically acceptable salt thereof as the active ingredient. The administration of DHAS or its salt to a patient with CFS serves to supplement the plasma DHAS decreased in the patient and recover the lowered immunocompetence, thereby remitting chronic general malaise, a feeling of exhaustion and psychoneurosis.
(FR)
Médicament qui agit contre le syndrome de fatigue chronique (SFC) et dont le composant actif est constitué par le sulfate de déhydroépiandrostérone (DHEA-S) ou par un sel pharmaceutiquement acceptable de celui-ci. L'administration de DHEA-S ou de son sel à un patient souffrant de SFC permet de suppléer au manque de DHEA-S dans le plasma du patient et de recouvrer la compétence immunitaire affaiblie; elle permet d'apaiser le malaise chronique généralisé ainsi que la sensation d'épuisement et la psychonévrose.
Also published as
US09284207
Latest bibliographic data on file with the International Bureau